45.65
Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
2.08%
621.99
|
609.29 | 578.66 | 568.25 | 564.69 |
|
|
28.26%
233.61
|
182.13 | 368.87 | 34.06 | -170.38 |
| Benefits Costs and Expenses |
61.18%
266.08
|
165.08 | 488.03 | 134.81 | -241.67 |
| Costs And Expenses |
28.26%
233.61
|
182.13 | 368.87 | 34.06 | -170.38 |
| Provision For Loan, Lease, And Other Losses |
319.10%
8.731
|
-3.985 | 7.911 | 13.51 | -33.72 |
| Operating Income/Loss |
9.08%
388.38
|
427.16 | 209.80 | 534.18 | 735.07 |
| Nonoperating Income/Loss |
290.38%
-32.47
|
17.05 | -119.16 | -100.75 | 71.28 |
| Income/Loss Before Equity Method Investments |
17.83%
351.91
|
428.26 | 87.94 | 426.99 | 795.95 |
| Income/Loss From Equity Method Investments |
74.89%
4.005
|
15.95 | 2.693 | 6.443 | 10.41 |
| Income/Loss From Continuing Operations Before Tax |
19.88%
355.91
|
444.21 | 90.64 | 433.43 | 806.36 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
19.88%
355.91
|
444.21 | 90.64 | 433.43 | 806.36 |
|
|
19.88%
355.91
|
444.21 | 90.64 | 433.43 | 806.36 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
9.16%
141.71
|
155.99 | 60.46 | 195.08 | 262.37 |
| Basic Average Shares |
100.11%
-0.48
|
431.89 | 423.51 | 435.48 | 447.63 |
| Diluted Average Shares |
100.41%
-2.299
|
559.61 | 562.30 | 578.10 | 592.73 |
| Basic Earnings Per Share |
25.37%
0.50
|
0.67 | 0.07 | 0.55 | 1.22 |
| Diluted Earnings Per Share |
25.37%
0.50
|
0.67 | 0.07 | 0.55 | 1.21 |
| Common Stock Dividends |
0.00%
0.22
|
0.22 | 0.22 | 0.22 | 0.21 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):